Kyntra Bio (KYNB) Cash & Equivalents (2014 - 2026)
Kyntra Bio's Cash & Equivalents was $50.64 million in Q2 2026, up 116.7% from $23.37 million a year earlier and up 36.9% from the prior quarter.
Powered by 
Analysis
Kyntra Bio (KYNB) Cash & Equivalents (2014 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Kyntra Bio came in at $47.87 million, down 53.1% from FY2024.
- Cash & Equivalents has now declined for five consecutive years, with a five-year compound annual growth rate of -41.2% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $102.18 million in FY2024 (-10.1%), $113.69 million in FY2023 (-27.0%), $155.7 million in FY2022 (-9.1%) and $171.22 million in FY2021 (-74.8%).
- Quarterly Cash & Equivalents has moved between $23.37 million (Q2 2025) and $274.53 million (Q3 2021) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in three of the last eight quarters, with an average decline of 11.2%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2026 (growth of 116.7%); the worst was Q2 2025 (a decline of 83.4%).
- Per Business Quant data, KYNB's Cash & Equivalents in the three quarters before Q2 2026 was $37 million (Q1 2026), $47.87 million (Q4 2025) and $117.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Kyntra Bio | 20.73 Mn | -365.73 Mn | 1.47 Mn | 50.64 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.64 Mn |
| Mar 31, 2026 | 37.00 Mn |
| Dec 31, 2025 | 47.87 Mn |
| Sep 30, 2025 | 117.98 Mn |
| Jun 30, 2025 | 23.37 Mn |
| Mar 31, 2025 | 33.61 Mn |
| Dec 31, 2024 | 102.18 Mn |
| Sep 30, 2024 | 131.00 Mn |
| Jun 30, 2024 | 140.71 Mn |
| Mar 31, 2024 | 105.73 Mn |
| Dec 31, 2023 | 113.69 Mn |
| Sep 30, 2023 | 120.91 Mn |
| Jun 30, 2023 | 152.59 Mn |
| Mar 31, 2023 | 188.55 Mn |
| Dec 31, 2022 | 155.70 Mn |
| Sep 30, 2022 | 155.96 Mn |
| Jun 30, 2022 | 167.76 Mn |
| Mar 31, 2022 | 185.90 Mn |
| Dec 31, 2021 | 171.22 Mn |
| Sep 30, 2021 | 274.53 Mn |
API Access
Kyntra Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KYNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "KYNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=KYNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();